Related Experiment Video

Updated: Aug 15, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Relation between sodium-lithium countertransport and hypertriglyceridemia in type V hyperlipidemia

A S Wierzbicki1, T C Hardman, J Cheung

  • 1Department of Chemical Pathology, St. Thomas' Hospital, London, UK. anthony.wierzbicki@kcl.ac.uk

American Journal of Hypertension
|February 24, 2001
PubMed

Insights

Type V hyperlipidemia patients show increased sodium-lithium countertransport (SLC) activity, strongly linked to very low-density lipoprotein (VLDL) triglycerides. This suggests a connection between lipid metabolism and SLC kinetics in this condition.

Area of Science:

  • Biochemistry
  • Human Physiology
  • Metabolic Disorders

Background:

  • Type V hyperlipidemia is characterized by elevated triglycerides and very low-density lipoprotein (VLDL) cholesterol.
  • Sodium-lithium countertransport (SLC) is a key transporter involved in cellular ion balance.
  • Understanding SLC kinetics in hyperlipidemia may offer insights into metabolic regulation.

Purpose of the Study:

  • To investigate sodium-lithium countertransport (SLC) kinetics in patients with type V hyperlipidemia.
  • To compare SLC activity and maximal velocity between type V hyperlipidemia, type IIB hyperlipidemia, and healthy controls.
  • To determine correlations between SLC parameters and clinical/biochemical markers in type V hyperlipidemia.

Main Methods:

  • Measured SLC kinetics (activity and maximal velocity) in erythrocytes of 30 type V hyperlipidemia patients, 30 type IIB hyperlipidemia patients, and 30 healthy controls.
  • Collected anthropometric, blood pressure, lipid biochemistry, glucose, insulin, and leptin data.
  • Analyzed correlations between SLC maximal velocity and various clinical and biochemical parameters, including VLDL triglycerides and insulin resistance.

Main Results:

  • Patients with type V hyperlipidemia exhibited higher obesity, elevated triglycerides, glucose, and insulin, with reduced HDL cholesterol compared to type IIB controls.
  • Median SLC activity and maximal velocity were numerically higher in type V hyperlipidemia patients but not statistically significant compared to controls.
  • SLC maximal velocity showed a strong positive correlation with log triglycerides (r²=0.853) and log VLDL triglycerides (r²=0.947) in type V hyperlipidemia patients.

Conclusions:

  • Very low-density lipoprotein (VLDL) triglyceride levels are strongly correlated with sodium-lithium countertransport (SLC) maximal velocity and activity in type V hyperlipidemia.
  • While not statistically significant in this cohort, trends suggest potentially altered SLC kinetics in type V hyperlipidemia.
  • SLC transporter sodium affinity remained independent of clinical and biochemical parameters across all groups.

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Related Concept Videos

Lipid Digestion01:06

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...